- Exchange: Tel Aviv
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for BioLine RX Ltd (BLRX)
| Open: | 63.00 | Day's Range: | 61.10 - 63.10 | Volume: | 1,329,773 |
|---|---|---|---|---|---|
| Previous Close: | 61.70 | 52wk Range: | 60.20 - 180.80 | 1-Yr Rtn: | -38.79% |
Key Statistics for BLRX
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. TA-100 | - |
| Earnings Per Share (ttm) | -0.3886 |
| Est. EPS (12/2013) | - |
| Est. PEG Ratio | - |
| Market Cap (M ILS) | 139.42 |
| Shares Outstanding (M) | 225.97 |
| 30 Day Average Volume | 1,368,810 |
| Price/Book (mrq) | 2.0267 |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/14/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for BLRX
Company Profile & Key Executives for BLRX
BioLineRx Ltd. is a biopharmaceutical development company. The Company develops clinical-stage therapeutic pharmaceutical drugs.
| Aharon SchwartzChairman | Kinneret Livnat SavitskyChief Executive Officer |
| Philip SerlinCFO/COO | David MalekVP:Business Development |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
BLRX News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page